176 related articles for article (PubMed ID: 1732994)
1. 1,3-Butadiene: toxicity and carcinogenicity in laboratory animals and in humans.
Melnick RL; Huff J
Rev Environ Contam Toxicol; 1992; 124():111-44. PubMed ID: 1732994
[TBL] [Abstract][Full Text] [Related]
2. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
3. Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene.
Bond JA; Medinsky MA
Chem Biol Interact; 2001 Jun; 135-136():599-614. PubMed ID: 11397415
[TBL] [Abstract][Full Text] [Related]
4. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
5. 1,3-butadiene: cancer, mutations, and adducts. Part I: Carcinogenicity of 1,2,3,4-diepoxybutane.
Henderson RF; Barr EB; Belinsky SA; Benson JM; Hahn FF; Ménache MG
Res Rep Health Eff Inst; 2000 Mar; (92):11-43; discussion 45-8. PubMed ID: 10925838
[TBL] [Abstract][Full Text] [Related]
6. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
[TBL] [Abstract][Full Text] [Related]
7. Inhalation toxicology and carcinogenicity of 1,3-butadiene in B6C3F1 mice following 65 weeks of exposure.
Melnick RL; Huff JE; Roycroft JH; Chou BJ; Miller RA
Environ Health Perspect; 1990 Jun; 86():27-36. PubMed ID: 2401263
[TBL] [Abstract][Full Text] [Related]
8. Comparative carcinogenicity of 1,3-butadiene, isoprene, and chloroprene in rats and mice.
Melnick RL; Sills RC
Chem Biol Interact; 2001 Jun; 135-136():27-42. PubMed ID: 11397379
[TBL] [Abstract][Full Text] [Related]
9. Carcinogenicity of 1,3-butadiene.
Melnick RL; Shackelford CC; Huff J
Environ Health Perspect; 1993 Apr; 100():227-36. PubMed ID: 8354171
[TBL] [Abstract][Full Text] [Related]
10. A review of the genetic and related effects of 1,3-butadiene in rodents and humans.
Jackson MA; Stack HF; Rice JM; Waters MD
Mutat Res; 2000 Oct; 463(3):181-213. PubMed ID: 11018742
[TBL] [Abstract][Full Text] [Related]
11. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures.
Thornton-Manning JR; Dahl AR; Allen ML; Bechtold WE; Griffith WC; Henderson RF
Toxicol Sci; 1998 Feb; 41(2):167-73. PubMed ID: 9520352
[TBL] [Abstract][Full Text] [Related]
12. Research strategy for assessing target tissue dosimetry of 1,3-butadiene in laboratory animals and humans.
Bond JA; Csanády GA; Leavens T; Medinsky MA
IARC Sci Publ; 1993; (127):45-55. PubMed ID: 8070886
[TBL] [Abstract][Full Text] [Related]
13. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene.
Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF
Carcinogenesis; 1995 Aug; 16(8):1723-31. PubMed ID: 7634396
[TBL] [Abstract][Full Text] [Related]
14. 1,3-Butadiene induces cancer in experimental animals at all concentrations from 6.25 to 8000 parts per million.
Melnick RL; Huff JE
IARC Sci Publ; 1993; (127):309-22. PubMed ID: 8070878
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the disposition of butadiene epoxides in Sprague-Dawley rats and B6C3F1 mice following a single and repeated exposures to 1,3-butadiene via inhalation.
Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF
Toxicology; 1997 Nov; 123(1-2):125-34. PubMed ID: 9347927
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice.
Csanády GA; Guengerich FP; Bond JA
Carcinogenesis; 1992 Jul; 13(7):1143-53. PubMed ID: 1638680
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace.
Bond JA; Recio L; Andjelkovich D
Carcinogenesis; 1995 Feb; 16(2):165-71. PubMed ID: 7859344
[TBL] [Abstract][Full Text] [Related]
18. The use of toxicologic data in mechanistic risk assessment: 1,3-butadiene as a case study.
Bond JA; Himmelstein MW; Medinsky MA
Int Arch Occup Environ Health; 1996; 68(6):415-20. PubMed ID: 8891778
[TBL] [Abstract][Full Text] [Related]
19. Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation.
Himmelstein MW; Turner MJ; Asgharian B; Bond JA
Carcinogenesis; 1994 Aug; 15(8):1479-86. PubMed ID: 8055623
[TBL] [Abstract][Full Text] [Related]
20. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene.
Nauhaus SK; Fennell TR; Asgharian B; Bond JA; Sumner SC
Chem Res Toxicol; 1996 Jun; 9(4):764-73. PubMed ID: 8831821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
